Gabelli Funds’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

Gabelli Funds’s Portfolio NVET Stock Details NVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-87,900	Closed	-$588K	–	1158
2017 Q2	$588K	Buy	+87,900	New	+$553K	﹤0.01%	975

Gabelli Funds's NVET Position: Q3 2017 in Review

Gabelli Funds sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q3 2017, closing a stake of 87,900 shares — an estimated $588K sold.

Gabelli Funds first reported a position in NVET in Q2 2017 and held it in 1 quarter. The position peaked at $588K in Q2 2017. 0 funds tracked by Wall St. Rank hold NVET as of Q3 2017.

Gabelli Funds reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q3 2017 after selling out during the quarter.
Gabelli Funds sold 87,900 Nexvet Biopharma plc Ordinary Shares shares in Q3 2017, an estimated $588K.
Gabelli Funds first reported a position in Nexvet Biopharma plc Ordinary Shares in Q2 2017 and held it in 1 quarter.
Gabelli Funds's Nexvet Biopharma plc Ordinary Shares position peaked at $588K in Q2 2017.
0 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q3 2017.

Based on Gabelli Funds's 13F filing for Q3 2017, filed 1 Nov 2017.